AT
Healthcare & Life Sciences

Avalo Therapeutics

Avalo Therapeutics is a Healthcare & Life Sciences startup based in Wayne, the United States, most recent round Series C+, 1 tracked investor.

Activeseries-c-plus
series-c-plus
Stage
1
Investors

About Avalo Therapeutics

Avalo Therapeutics is a company headquartered in Wayne, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Avalo Therapeutics is a clinical stage biotechnology company developing novel IL-1β targeting therapies for immune-mediated inflammatory diseases such as hidradenitis suppurativa.

Explore Avalo Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States